These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 4031292

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB, Rasul AM, Shah A, Adams E, Flessas A, Kocot SL.
    Am J Cardiol; 1984 Jan 01; 53(1):84-7. PubMed ID: 6362388
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias.
    Giardina EG, Wechsler ME.
    J Am Coll Cardiol; 1990 Apr 01; 15(5):1138-45. PubMed ID: 2179362
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mexiletine. Use in control of chronic drug-resistant ventricular arrhythmia.
    Abinader EG, Cooper M.
    JAMA; 1979 Jul 27; 242(4):337-9. PubMed ID: 448936
    [Abstract] [Full Text] [Related]

  • 32. Clinical antiarrhythmic efficacy of mexiletine: a review.
    Kulbertus HE.
    Acta Cardiol Suppl; 1980 Jul 27; (25):111-20. PubMed ID: 6990663
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mexiletine: double-blind comparison with procainamide in PVC suppression and open-label sequential comparison with amiodarone in life-threatening ventricular arrhythmias.
    Nademanee K, Feld G, Hendrickson J, Intarachot V, Yale C, Heng MK, Singh BN.
    Am Heart J; 1985 Nov 27; 110(5):923-31. PubMed ID: 3904380
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
    Kim SG, Mercando AD, Tam S, Fisher JD.
    J Am Coll Cardiol; 1989 Mar 01; 13(3):659-64. PubMed ID: 2918173
    [Abstract] [Full Text] [Related]

  • 40. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B, Volpe M, Ricciardelli B, Sacca' L, De Luca N, Rengo F, Condorelli M.
    Arch Int Pharmacodyn Ther; 1980 Dec 01; 248(2):251-9. PubMed ID: 7013721
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.